✨ Free AI Report
Carlsmed, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Carlsmed, Inc.
Company Research

Carlsmed, Inc.: Business Overview, Financials & Competitive Analysis

Carlsmed, Inc. scores 8/10 on the AskCyborg Cyborg Score (Strong). High-growth, AI-enabled spine surgery platform with strong clinical outcomes, recent public market entry, and expanding product portfolio positioned for sustained market penetration. Carlsmed demonstrates exceptional commercial momentum with 58% YoY growth in Q1 2026, strong gross margins at 75.3%, and successful product expansion from lumbar to cervical spine procedures. Recent.

What is Carlsmed, Inc.'s industry? Carlsmed, Inc. (carlsmed.com) operates in Orthopedic Devices. AskCyborg classifies Carlsmed, Inc. under Orthopedic Devices in its company registry.

Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions. The company specializes in personalized spine surgical solutions, using artificial intelligence and advanced 3D surg...

8/ 10Strong

Cyborg Score thesis

High-growth, AI-enabled spine surgery platform with strong clinical outcomes, recent public market entry, and expanding product...

Read the full analyst-debate transcript →
Industry Orthopedic Devices
4 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 21, 2026
AI-Verified Research
30+ Page Report

Get the Latest Carlsmed, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Carlsmed, Inc.

AskCyborg analysts argue the bull and bear cases for Carlsmed, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Carlsmed, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Carlsmed, Inc. Overview

Pro stress-test →

Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions. The company specializes in personalized spine surgical solutions, using artificial intelligence and advanced 3D surgical planning to create custom implants tailored to individual patients. The Carlsmed aprevo® personalized surgery platform is designed to improve the standard of care for spine surgery one patient at a time.

Strategic Profile

Pro stress-test →

Carlsmed delivered Q1 2026 revenue of $16.1 million, representing 58% growth year-over-year, with full year 2026 revenue guidance raised to $72-$77 million. The company achieved 86% revenue growth in 2025, driven by strong lumbar platform performance and new cervical product launches, with gross margins expanding to 75.3%. Carlsmed began trading on the Nasdaq Global Select Market under ticker CARL on July 23, 2025.

Competitive Landscape

Pro stress-test →

Carlsmed competes in the personalized orthopedic implant and AI-driven surgical planning market against traditional spine device manufacturers and emerging digital surgery platforms. The company's rapid revenue growth and strong clinical validation drive adoption of its personalized spine surgery platform, now expanded to both lumbar and cervical procedures, with new reimbursement wins and technological innovations supporting continued U.S. market expansion.

Industry Context

Carlsmed, Inc. operates in Orthopedic Devices.

Key facts

Founded: 2018 · Headquarters: Carlsbad, California, US · Employees: 101-250 · Revenue: $16.1M (Q1 2026); $50.5M (FY 2025) · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for Carlsmed, Inc..

  • (May 2026) Full-year 2026 revenue guidance raised to $72-77M, implying 44% expected growth at midpoint, reflecting strong Q1 execution
  • (Q1 2026) 58% YoY revenue growth with gross margin of 75.3%, demonstrating operational leverage and commercial traction
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • May 2026Full year 2026 revenue guidance raised to $72-77 million; Q1 2026 revenue $16.1 million
  • February 2026Full year 2025 revenue reported at $50.5 million with 86% YoY growth; Q4 2025 revenue $15.2 million
  • +2 moreTrack every material event for Carlsmed, Inc. as it happens. Explore monitoring →
Get alerted when Carlsmed, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Globus MedicalAI-enabled surgical planning and personalized spine solutions→NuVasiveDigital spine surgery platform with AI-enabled surgical planning→ArthrexPersonalized orthopedic surgical solutions and implants→ChoiceSpinePatient-specific spine implants and surgical planning→

Compare Carlsmed, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Carlsmed, Inc. operates in Orthopedic Devices. See how the rest of the sector scores on the Cyborg framework.

Browse Orthopedic Devices research →
NEW · MCP server

Ask your AI assistant about Carlsmed, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Carlsmed, Inc. and its top competitor on Cyborg Score”
“What did Carlsmed, Inc. do this quarter?”
“Is Carlsmed, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Carlsmed, Inc. do?+
Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions. The company specializes in personalized spine surgical solutions, using artificial intelligence and advanced 3D surg...
What is Carlsmed, Inc.'s Cyborg Score?+
Carlsmed, Inc. has a Cyborg Score of 8/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Carlsmed, Inc.'s main competitors?+
Named competitors include Globus Medical, NuVasive, Arthrex, ChoiceSpine. The full competitive landscape is in the AskCyborg report.
How can I get the full Carlsmed, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Carlsmed, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Carlsmed, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.